Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1993
11/03/1993EP0567572A1 Immortalized human cell lines
11/03/1993EP0567568A1 $i(TRANS)-SPLICING RIBOZYMES
11/03/1993EP0567567A1 A RECEPTOR TYROSINE KINASE TARGET PROTEIN cDNA CLONING METHOD AND hGRB PROTEINS
11/03/1993EP0567512A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine
11/03/1993EP0567508A1 Macroscopically oriented cell adhesion protein for wound treatment
11/03/1993EP0567503A1 Pasteurella haemolytica glycoprotease gene
11/03/1993EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/03/1993EP0567450A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
11/03/1993EP0559868A4 An assay for a new gaucher disease mutation
11/03/1993EP0477198B1 Method for recovering recombinant proteins
11/03/1993CN1077991A Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/03/1993CN1077990A Root knot nematode resistance
11/02/1993US5258502 Immobilization and purification of fusion proteins using chitin-binding ability
11/02/1993US5258498 Targeted multifunctional proteins, immunological treatment of cancer and infection
11/02/1993US5258496 Precipitation and extraction of proteins
11/02/1993US5258494 Dimeric protein capable of inducing bone and cartilage formation when implanted, in association with a matrix, in a mammal
11/02/1993US5258368 Polypeptides
11/02/1993US5258302 DNA for expression of aprotinin in methylotrophic yeast cells
11/02/1993US5258300 Method of inducing lysine overproduction in plants
11/02/1993US5258298 Deletion and glycosylation mutant of human tissue plasminogen activator
11/02/1993US5258294 Plasmid cloning vector with genomic library from DNA and virus isolation and insertion a promoter element
11/02/1993US5258292 Hydrolysis of adipamide or ammonium adipamate by contact with amidase or microorganism that generates such polypeptide
11/02/1993US5258289 Specific cleavage of immunoglobulin E class peptides, allergy treatment
11/02/1993US5258288 DNA sequences and genetic vectors
11/02/1993US5258287 DNA sequences and hybrids
11/02/1993US5258180 For treating vascular conditions or disease
11/02/1993US5258178 Antibodies from cows milk which prevent gastritis
11/02/1993CA2094987A1 Human glutamate receptor proteins and associated dna compounds
11/02/1993CA1323851C Expression of human proapolipoprotein a-i
11/02/1993CA1323850C Kluyveromyces as a host strain
10/1993
10/28/1993WO1993021526A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF β-AMYLOID PRECURSOR PROTEIN
10/28/1993WO1993021347A1 Transcription control element for increasing gene expression in myoblasts
10/28/1993WO1993021342A1 Probes for detecting common liveborn chromosomal aneuploidies
10/28/1993WO1993021340A1 Dna sequencing method
10/28/1993WO1993021339A1 Quantitative viral assay
10/28/1993WO1993021337A1 Gustducin materials and methods
10/28/1993WO1993021335A2 Transformation of monocot cells
10/28/1993WO1993021334A1 Dna constructs and plants incorporating them
10/28/1993WO1993021333A1 Yeast strains capable of fermenting rapidly sugars with rapid production of carbon dioxide and ethanol; production and utilization of such strains
10/28/1993WO1993021331A2 Polysaccharide binding fusion proteins and conjugates
10/28/1993WO1993021330A1 Human glutamine:fructose-6-phosphate amino-transferase
10/28/1993WO1993021329A1 Virus resistant plants
10/28/1993WO1993021328A1 Polypeptides having kinase activity, their preparation and use
10/28/1993WO1993021327A1 Immortalized human cell lines containing exogenous cytochrome p450 genes
10/28/1993WO1993021326A2 Method of cloning a dna sequence coding for a plant nadph-cytochrome p450 reductase and associated dna sequences
10/28/1993WO1993021325A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993WO1993021324A1 Recombinant mutants for inducing specific immune responses
10/28/1993WO1993021323A1 Haemophilus somnus immunogenic proteins
10/28/1993WO1993021322A1 A method for controlling and determining plant organ morphogenesis, a homeotic gene, a promoter element therefor, and related uses thereof
10/28/1993WO1993021321A2 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA)
10/28/1993WO1993021320A1 Oil-body proteins as carriers of high-value peptides in plants
10/28/1993WO1993021319A1 HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
10/28/1993WO1993021318A1 Lymphocyte activation antigen hb15, a member of the immunoglobulin superfamily
10/28/1993WO1993021317A1 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN β SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
10/28/1993WO1993021316A1 Mammalian melanocyte stimulating hormone receptors and uses
10/28/1993WO1993021315A1 Mammalian adrenocorticotropic hormone receptors and uses
10/28/1993WO1993021314A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993WO1993021313A1 Cloning and characterization of a gene, inducible by cytokines
10/28/1993WO1993021312A1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides
10/28/1993WO1993021311A1 Immortalisation of human cells by gene silencing
10/28/1993WO1993021309A1 Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics
10/28/1993WO1993021307A1 CLONING AND EXPRESSING RESTRICTION ENDONUCLEASES AND MODIFICATION METHYLASES FROM $i(XANTHOMONAS)
10/28/1993WO1993021306A1 Genetically engineered attenuated viruses
10/28/1993WO1993021303A2 Enhanced purification and expression of insoluble recombinant proteins
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021232A1 IMMUNOTOXINS DIRECTED AGAINST c-erbB-2 (HER-2/neu) RELATED SURFACE ANTIGENS
10/28/1993WO1993021229A1 Methods and compositions for the treatment of diseases with interferon while reducing side effects
10/28/1993WO1993021226A1 Cartilage matrix protein and methods for use
10/28/1993WO1993021218A1 Synthetic polypeptides derived from the hiv envelope glycoprotein
10/28/1993WO1993021203A1 Synthesis of diverse and useful collections of oligonucleotides
10/28/1993WO1993021202A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/28/1993WO1993020848A1 Immunotoxins directed against cd33 related surface antigens
10/28/1993WO1993020844A1 Papillomavirus e7 protein
10/28/1993WO1993020841A1 Antibodies specific for carcinoma-associated antigens
10/28/1993WO1993020694A1 Method and composition for inhibition of viral replication
10/28/1993WO1993020691A1 Method for inducing tumor immunity
10/28/1993WO1993020686A1 Plant resistant to two or more viruses and preparation thereof
10/28/1993WO1993019089A3 Oxygen carrier
10/28/1993WO1993018169A3 Expression cassette and plasmids for a guard cell specific expression and their use for the introduction of transgenic plant cells and plants
10/28/1993WO1993018168A3 Transgenic wheat
10/28/1993WO1993018166A3 PRODUCTION OF $i(ASPERGILLUS NIGER CATALASE-R)
10/28/1993WO1993018154A3 Method for enhancing plant precocity and/or reducing the stored nitrate content of a plant
10/28/1993WO1993018148A3 Tumor necrosis factor with modified channel activity
10/28/1993WO1993014206A3 Synthetic peptides for a rubella vaccine
10/28/1993WO1993013196A3 Method for increasing recombinant protein production
10/28/1993WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination
10/28/1993DE4213497A1 New human interferon gamma (HIFNG) monoclonal antibodies - produced by immunising mice with spleen cells from mice having high serum antibody titre for HIFNG, followed by immobilised HIFNG
10/28/1993DE4213444A1 Prodn. of potato plants with suppressed tuber sprouting - by genetic modification to reduce sucrose concn.
10/28/1993CA2388198A1 Adrenocorticotropic hormone receptor and uses
10/28/1993CA2133999A1 Recombinant mutants for inducing specific immune responses
10/28/1993CA2133739A1 Immunotoxins directed against c-erbb-2 (her-2/neu) related surface antigens
10/28/1993CA2133566A1 Transcription control element for increasing gene expression by myoblasts
10/28/1993CA2133339A1 Wild-type measles virus glycoproteins: vaccine and detection method therefor
10/28/1993CA2131166A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization
10/28/1993CA2118234A1 Genetically engineered attenuated viruses
10/28/1993CA2118123A1 Method for inducing tumor immunity
10/28/1993CA2118033A1 Synthetic polypeptides derived from the hiv envelope gylcoprotein
10/28/1993CA2117887A1 Polysaccharide binding fusion proteins and conjugates
10/28/1993CA2117783A1 Probes for detecting common liveborn chromosomal aneuploidies
10/28/1993CA2117780A1 Cartillage matrix protein and methods for use